Table 2.
Chemical parameters and cholesterol efflux capacity at baseline and follow up.
| Non Diabetes (n = 48) | Diabetes Mellitus (n = 37) | P Value | |
|---|---|---|---|
| Baseline | |||
| Total Cholesterol, mg/dl | 152.0 ± 42.1 | 155.1 ± 48.7 | 0.94 |
| LDL Cholesterol, mg/dl | 87.8 ± 37.4 | 85.5 ± 42.7 | 0.318 |
| HDL Cholesterol, mg/dl | 42.9 ± 12.6 | 39.3 ± 12.6 | 0.13 |
| Triglyceride,, mg/dl | 106.5 ± 59.8 | 155.0 ± 148.8 | 0.11 |
| ApoA1, mg/dl | 121.4 ± 24.5 | 118.5 ± 27.1 | 0.48 |
| hs-CRP, mg/dl | 3.2 ± 5.5 | 3.8 ± 5.9 | 0.13 |
| HbA1C, % (mmol/mol) | 5.9 ± 0.4 (41 ± 4.4) | 8.3 ± 2.0 (67 ± 21.9) | <0.001 |
| Cholesterol Efflux Capacity | 81.1 ± 0.1 | 80.4 ± 0.2 | 0.68 |
| Follow up | |||
| Total Cholesterol, mg/dl | 119.8 ± 29.9 | 109.4 ± 29.2 | 0.045 |
| change | −32.3 ± 39.0 | −45.7 ± 45.0 | 0.11 |
| p value | <0.001 | <0.001 | |
| LDL Cholesterol, mg/dl | 55.3 ± 28.3 | 43.4 ± 20.6 | 0.06 |
| change | −32.5 ± 32.5 | −41.1 ± 41.8 | 0.37 |
| p value | <0.001 | <0.001 | |
| HDL Cholesterol, mg/dl | 44.5 ± 11.6 | 41.2 ± 17.7 | 0.058 |
| change | 1.5 ± 8.8 | 1.9 ± 13.4 | 0.53 |
| p value | 0.261 | 0.76 | |
| Triglyceride, mg/dl | 96.1 ± 49.0 | 120.6 ± 81.0 | 0.14 |
| change | −10.4 ± 49.8 | −34.4 ± 154.7 | 0.66 |
| p value | 0.18 | 0.14 | |
| ApoA1, mg/dl | 132.1 ± 20.7 | 120.7 ± 25.0 | 0.011 |
| change | 11.38 ± 24.7 | 1.6 ± 16.0 | 0.049 |
| p value | 0.003 | 0.47 | |
| hs-CRP, mg/dl | 2.17 ± 3.5 | 3.23 ± 5.0 | 0.034 |
| change | −0.9 ± 4.1 | −0.5 ± 5.0 | 0.62 |
| p value | 0.001 | 0.058 | |
| HbA1c | 6.0 ± 0.5 (42 ± 5.5) | 8.2 ± 1.6 (66 ± 1.6) | <0.001 |
| change | 0.04 ± 0.2 (0.4 ± 2.2) | −0.11 ± 1.6 (−1.2 ± 17.5) | 0.27 |
| p value | 0.34 | 0.62 | |
| Cholesterol Efflux Capacity | 85.3 ± 0.1 | 83.7 ± 0.2 | 0.20 |
| change | 0.04 ± 0.1 | 0.03 ± 0.7 | 0.83 |
| p value | 0.007 | 0.015 | |
Values are mean ± SD
*LDL denotes low density lipoprotein cholesterol, HDL high density lipoprotein cholesterol, Apo-AI apolipoprotein AI, hs-CRP high-sensitivity C-reactive protein.